Therapeutic Combinations Of Orally Administered Paclitaxel, A P-gp Inhibitor, And A Checkpoint Inhibitor For The Treatment Of Solid Tumors

The application pertains to pharmaceutical combinations of orally administered paclitaxel, a P-gp inhibitor, and a checkpoint inhibitor. The pharmaceutical combinations are suitable for the treatment of a cancer (e.g., lung cancer) in a subject.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KWAN, Min-Fun Rudolf, SMOLINSKI, Michael P, LAU, Johnson Yiu-Nam, CUTLER, David Lawrence
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The application pertains to pharmaceutical combinations of orally administered paclitaxel, a P-gp inhibitor, and a checkpoint inhibitor. The pharmaceutical combinations are suitable for the treatment of a cancer (e.g., lung cancer) in a subject.